key: cord-0910808-kgxia2jn
authors: Winkley, K.; Banerjee, D.; Louiselle, D.; Biswell, R.; Posey, N.; Fatheree, K.; McDanel, S.; Bradley, T.; Moffatt, M. E.; Koseva, B.; Cheung, W. A.; Johnston, J. J.; Selvarangan, R.; Pastinen, T.; Grundberg, E.
title: Immune cell residency in the nasal mucosa and COVID-19 severity across the age range
date: 2021-02-08
journal: nan
DOI: 10.1101/2021.02.05.21251067
sha: 9396c3f7b030d2577de51dcb76610c7b8237851e
doc_id: 910808
cord_uid: kgxia2jn

Severe coronavirus disease of 2019 (COVID-19) positively correlates with age (Centers for Disease Control), develops after progression of infection from the upper airway to the lower respiratory tract (LRT), and can worsen into acute respiratory distress syndrome (ARDS). Why children seem to be less likely to develop severe disease remains unclear. As the nasal mucosa (NM) is the first site of contact and defense for respiratory pathogens such as SARS-CoV-2 before dissemination to the LRT, we hypothesized that differences in this tissue across the age range may help explain the disparity in COVID-19 severity. To this end, we profiled NM samples across the lifespan in health and disease. We find that global transcriptomic changes including the expression of SARS-CoV-2 and coronavirus-associated receptors and factors are not correlated with age or the novel virus type, since pediatric NM cells mount similar antiviral response to both SARS-CoV-2 or Influenza B. Rather, we find immune cell residency in NM decreases dramatically with age especially cells of the innate immune system. This includes a resident-memory-like T cell subset with antiviral properties. These observations give plausible biological explanation to the observed clinical differences in disease spectrum and provide a foundation for future experimental studies.

We characterized the composition of the NM across the lifespan, by taking advantage of 29 readily available clinical samples of NM-derived cells from COVID-19-negative pediatric patients 30 and healthcare workers. We developed a protocol to collect viable cells from salvaged 31 respiratory specimens collected by mid-turbinate swabs shortly after completion of clinical 32 testing. We used a specimen pooling approach, where isolated cells from four to nine 33 deidentified individuals of similar age groups were combined into a common. This increased 34 coverage of cell types in the age-specific pools, and also averaged out the effects of individual 35 heterogeneity, resulting in more accurate population level sampling. Applying single-cell RNA 36 sequencing (scRNAseq), our approach resulted in the transcriptomic profiling of ~30,000 cells 37 across six pools with average ages of 1, 7, 13, 17, 33, and 50 years which effectively covers the 38 vast majority of the lifespan. 39

We detected the expected epithelial and immune cell types in our data (Fig 1a) . The Additionally, we were able to identify CFTR expressing ionocytes (Plasschaert et al., 2018) . We 46 confirmed our cell type assignments by comparing marker genes for each cell type to previously Ziegler et al., 2020). Additionally, we explored genome wide expression differences in the NM 95 with respect to age. We found little evidence of fundamental expression changes independent 96 of cell type across the age range that might contribute to the muted severity of COVID-19 in 97 younger individuals (Extended Data Fig 4a-b) . From this, we conclude that variation in observed 98 disease severity across the age range are unlikely to be explained by transcriptomic differences, 99 but rather differences in immune cell residency. 100

Next, we hypothesized that the pediatric response to SARS-CoV-2 may be altered in 101 some way that may contribute to mild disease, such as an upregulation of anti-inflammatory 102 molecules, or activation of an immunosuppressive cell type. To test this, we performed 103 scRNAseq on NM samples of three COVID-19 positive pediatric patients (5-11 years). We found 104 that pediatric NM cells were not unexpectedly refractory to SARS-CoV-2 infection (Extended 105 Data Fig 5) , and that pediatric COVID-19 positive patients did not display increased immune cell 106 infiltration of the NM (Fig 4a-b) . We tested for activity of immune cells by quantifying cell-cell 107 interactions via expression patterns of ligand-receptor pairs (Efremova et al., 2020). We 108 observed a slight increase in epithelial-to-immune interactions in COVID-19 positive children 109 compared to COVID-19 negative children especially in T cells and monocytes (Extended Data Fig  110   6a ) further highlighting the role of the innate immune system. However, these interactions did 111 not result in marked increase in cell death of epithelial cells (Extended Data Fig 6b) . This is in 112 stark contrast to the NM immune response in adults with moderate and severe COVID-19 113

where dramatic infiltration of immune cells and resulting epithelial cell death are observed. 114 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint However, in line with other reports, we did note a strong upregulation of interferon signaling in 115 the NM of COVID-19 positive pediatric patients (Fig 4c) . 116

To further characterize the immune response to SARS-CoV-2 in children versus adults, 117 we expanded our COVID-19 pediatric cell atlas by including peripheral blood mononuclear cells 118 of these same COVID-19 positive children. We found that the peripheral immune response to 119 COVID-19 infection is quite similar to local NM immune response. There are no significant 120 expansions of specific immune cell types in the periphery (Extended Data Fig 7a- in the periphery is primarily marked by increased interferon signaling (Extended Data Fig 7c) . 124

This leads us to conclude that the pediatric immune response to COVID-19 is not altered in an 125 unexpected and immunosuppressive way that results in more mild disease severity. Instead, 126 both the local and peripheral immune systems display the hallmarks of antiviral and interferon 127 signaling in response to viral infection. 128

Finally, we asked if this anti-viral response in the NM to COVID-19 infection in pediatric 129 patients is unique by nature of the novel Coronavirus. To test this, we contrasted our pediatric 130 COVID-19 NM profiles with age-and tissue-matched scRNAseq profiles derived from Influenza B 131 infected children. We found that the NM immune response to COVID-19 is strikingly similar to 132 the response to influenza B infection in pediatric patients (Fig 4a-c & Extended Data Fig 6) and 133 is primarily characterized by robust interferon signaling. (Fig 4d) . 134

In conclusion, we present the first-of-its kind single-cell atlas that spans the dimensions 135 of age, tissue, and virus types with important and novel coverage during childhood. Using this 136 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Trm may represent a reservoir of potential cross-reactive T-cells that offer protection from SARS-145

CoV-2 infection. Other studies will be needed to fully test this hypothesis, and our atlas 146 provides a foundation for them. 147

While our pooling strategy allowed us to obtain sufficient number of high-quality cells 148

for cataloging all major cell populations it limited our ability for high-powered interindividual 149 analysis of minor differences. Additionally, possible confounding factors including racial 150 differences among our study populations, and the effect of non-SARS-CoV-2 respiratory viruses 151 could not be fully explored. However, we performed orthogonal and multi-dataset external 152 validation whenever possible to try and identify if these factors created a major confounding 153 effect. In closing, our initial analyses of this resource raise the possibility that pediatric COVID-154 19 severity may be less because child and adolescent NM may be inherently primed for 155 immune response to SARS-CoV-2 and not because of unexpected transcriptional or immune 156 response differences across the age range. The increased presence and activity of resident 157 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. cell counter. The cell suspension was transferred to a 1.5-mL tube and centrifuged at 300 x g at 201 4°C for 8 minutes, and the supernatant was carefully removed without disturbing the cell pellet. 202

The cell pellet was resuspended in 1 mL of cold Recovery Cell Culture Freezing Medium 203 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint (Thermo Fisher Cat No. 12648010), and the cell suspension was transferred to a cryogenic 204 storage vial. The cryogenic storage vial was placed in a Corning CoolCell FTS30, which was then 205 placed in a -80°C freezer overnight. Samples were stored at -80°C for no longer than one week 206 before being thawed and processed for scRNAseq. 207

Cell pooling and single-cell RNA-sequencing of NM 208 Samples with less than 30% viability were excluded from analysis and cells were used in pools 209 or individually. For the lifespan atlas, six groups were formed based on the age of the patients: 210

Control Group 1) 4 months -18 months (n=7); Control Group 2) 5 years -9 years (n=5); Control 211 Each cryogenic storage vial containing a sample to be thawed was placed in the 37°C bead bath. 225 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. was prewarmed in a 37°C bead bath. When each cryopreserved sample was thawed and 267 diluted, as described above for the nasal samples, they were centrifuged at 300 x g for 8 min, 268 the supernatant was carefully aspirated, and the cell pellets were resuspended in 0.5 mL of 269 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Nasal specimens were stored at -80⁰C and were brought to room temperature before pooling 281 by age. Before pooling, the specimens were mixed well with gentle pipetting. 100µL from each 282 specimen was removed and pooled together in a 1.5mL tube. Once all specimen aliquots were 283 added to the pool, the pool was mixed by pipetting and 200μl was taken from each pool into a 284 new 1.5mL tube for DNA isolation. DNA was isolated with a DNeasy Blood and Tissue Kit 285 (Qiagen, Cat No. 69504) with the following modifications to kit protocol: 8uL of RNase A was 286 used instead of 4ul during the optional RNase A step and the lysis incubation time at 56⁰C was 287 increased to at least 3 hours to ensure complete lysis of the specimens. After isolation, the DNA 288 concentration of each sample was determined using a Qubit dsDNA HS Assay Kit (Fisher, Cat 289

No. Q32851). 290

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint 100ng of DNA was aliquoted from each sample. Unmethylated λDNA was added to each sample 292 at 0.5%w/v and the samples were sheared mechanically using a Covaris LE220-plus system to a 293 length of 350 bp, using the settings recommended by the manufacturer. The MarkDuplicates and subsequently removed. Bismark (Krueger and Andrews, 2011) was used to 333 assign the methylation ratio at each CpG site. CpG sites were filtered to remove sites that had 334 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint less than 10x coverage, overlapped ENCODE problematic regions, or overlapped sites in dbSNP 335 as previously described (Busche et al., 2015) . 336

Genome-wide age correlated expression 337

To identify pathways which were affected by age at a genome wide scale, we used a hurdle 338 model (Zeileis et al., 2008) to predict the effect of age on gene expression independently of cell 339 type. We used cell type as the predictor for the zero model with a binomal distribution, and 340 both age and cell type as the predictors for the counts model with a negative binomial 341 distribution. We identified genes where age had a significant effect The immune cell composition of the NM was inferred from the methylation profile of samples 347 that were independent of the single-cell RNA-sequencing samples. We measured CpG 348 methylation in regions that have been identified to be primarily accessible in lymphoid and 349 myeloid cells through large scale DNase 1 hypersensitive sequencing and analysis (Meuleman et 350 al., 2020) . The regions that were identified as invariantly accessible across cell types were used 351 as a control to test for overall methylation differences. We compared average methylation of 352 CpGs in these regions across the age range and tested for overall shifts in the distributions with 353 a Kruskal-Wallis test. In each case, the result was significant and all pairwise comparisons were 354 made using a Mann-Whitney U test. 355

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint defined as "expressing" a given gene if at least one UMI mapping to the gene was detected in 378 that cell. 379

Raw and processed data from all pooled samples is available via the Gene Expression Omnibus 381 (accession number: GSE162864). Raw data from individual samples are available upon request 382 through EGA and dbGAP upon approval from the Data Access Committee. Fully processed data 383 are available for exploration through the UCSC cell browser (lifespan-nasal-atlas.cells.ucsc.edu) 384

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint

The authors declare no competing interests. 395 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Cellular expression patterns of ACE2 (B), and TMPRSS2 (C) do not change appreciably across the 568 age range and are consistent with patterns described in previously published reports. 569 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 8, 2021. ; https://doi.org/10.1101/2021.02.05.21251067 doi: medRxiv preprint

Single cell profiling of COVID-19

Molecular determinants and heterogeneity of tissue-resident 444 memory CD8+ T lymphocytes revealed by single-cell RNA sequencing

CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other 447 coronavirus strains and influenza virus

Index and biological spectrum of human DNase I 450 hypersensitive sites

Coronavirus occurrence and transmission over 8 years in the 453 HIVE cohort of households in michigan

Notch3-Jagged signaling controls 456 the pool of undifferentiated airway progenitors

Injury Induces Direct Lineage Segregation of Functionally Distinct Airway Basal 459 Stem/Progenitor Cell Subpopulations

Resident memory CD8 + T cells in the upper respiratory tract 462 prevent pulmonary influenza virus infection

A single-cell atlas of the airway epithelium reveals the CFTR-rich 465 pulmonary ionocyte

CDC20B is required for deuterosome-468 mediated centriole production in multiciliated cells

Novel dynamics of human mucociliary 471 differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures

Tissue-resident memory T cells

An 476 overview of COVID-19

A Single-Cell RNA Expression Map of Human 478 Coronavirus Entry Factors

A Single-Cell RNA Expression Map of Human 480 Coronavirus Entry Factors

Resident-Memory T Cells in tissue-restricted 482 immune responses: For better or worse? Frontiers in Immunology 9

SARS-CoV-2 reactive T 484 cells in uninfected individuals are likely expanded by beta-coronaviruses

Comprehensive Integration of Single-Cell Data

Tissue-resident lymphocytes: from adaptive to 489 innate immunity

SARS-CoV-2 entry factors are highly 492 expressed in nasal epithelial cells together with innate immune genes

The noncoding and coding transcriptional landscape of the peripheral immune 496 response in patients with COVID-19

A single-cell atlas of the peripheral 499 immune response in patients with severe COVID-19

The differential immune responses to COVID-19 in peripheral and lung revealed by 502 single-cell RNA sequencing

Evolution of 504 the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike 505 protein for risk of human transmission

Regression Models for Count Data in R

Metascape provides a biologist-oriented resource for the analysis of